[go: up one dir, main page]

AU2001268366A1 - Tetrapyrroles - Google Patents

Tetrapyrroles

Info

Publication number
AU2001268366A1
AU2001268366A1 AU2001268366A AU6836601A AU2001268366A1 AU 2001268366 A1 AU2001268366 A1 AU 2001268366A1 AU 2001268366 A AU2001268366 A AU 2001268366A AU 6836601 A AU6836601 A AU 6836601A AU 2001268366 A1 AU2001268366 A1 AU 2001268366A1
Authority
AU
Australia
Prior art keywords
compound
manganese
complexed
carboxylic acid
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268366A
Other languages
English (en)
Inventor
Ines Batinic-Haberle
James D Crapo
Brian J Day
Irwin Fridovich
Ivan Spasojevic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Jewish Health
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Publication of AU2001268366A1 publication Critical patent/AU2001268366A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/456—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
AU2001268366A 2000-06-14 2001-06-14 Tetrapyrroles Abandoned AU2001268366A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21187500P 2000-06-14 2000-06-14
US60211875 2000-06-14
PCT/US2001/018944 WO2001096345A1 (fr) 2000-06-14 2001-06-14 Tetrapyrroles

Publications (1)

Publication Number Publication Date
AU2001268366A1 true AU2001268366A1 (en) 2001-12-24

Family

ID=22788641

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268366A Abandoned AU2001268366A1 (en) 2000-06-14 2001-06-14 Tetrapyrroles

Country Status (5)

Country Link
EP (1) EP1320532A1 (fr)
JP (1) JP2004503556A (fr)
AU (1) AU2001268366A1 (fr)
CA (1) CA2412623A1 (fr)
WO (1) WO2001096345A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
DE69813898T2 (de) 1997-11-03 2004-03-11 Duke University Substituierte porphyrinen
WO1999055388A1 (fr) 1998-04-24 1999-11-04 Duke University Porphyrines substituees
CN1156478C (zh) 1999-01-25 2004-07-07 国家犹太医疗及研究中心 取代的卟啉
US6902881B2 (en) 2000-10-13 2005-06-07 President And Fellows Of Harvard College Compounds and methods for regulating cell differentiation
US6908732B2 (en) 2000-10-13 2005-06-21 President & Fellows Of Harvard College Compounds and methods for regulating cell differentiation
WO2002055075A2 (fr) * 2000-11-10 2002-07-18 Harvard College Composes et procedes permettant de reguler la differentiation cellulaire
JP2005508864A (ja) 2001-06-01 2005-04-07 ナショナル・ジュウィッシュ・メディカル・アンド・リサーチ・センター 糖尿病の治療、または移植術における使用、または免疫寛容の誘導のためのオキシダントスカベンジャー
EP1513537A4 (fr) 2002-06-07 2006-09-06 Univ Duke Porphyrines substituees
EP1718201B1 (fr) 2004-02-09 2016-09-14 Duke University Porphyrines substituees
US20080070971A1 (en) * 2006-03-06 2008-03-20 Wang Xiang H Medical Use of Bilirubin and its Structural Analogues
JP4906583B2 (ja) * 2007-05-15 2012-03-28 株式会社日本自動車部品総合研究所 燃料性状検出装置
AU2009280042B2 (en) 2008-05-23 2015-06-04 National Jewish Health Methods for treating injury associated with exposure to an alkylating species
US8455222B2 (en) 2009-11-04 2013-06-04 Utah State University Biliverdin from a non-animal source
WO2014043647A1 (fr) * 2012-09-14 2014-03-20 Utah State University Compositions thérapeutiques et procédés associés
CN105693702B (zh) * 2016-01-15 2019-08-16 新疆大学 一种吡唑啉酮缩呋喃酰肼合铜配合物的制备及生物活性
KR102254093B1 (ko) * 2017-05-12 2021-05-20 주식회사 빌릭스 빌리루빈 유도체 및 금속을 포함하는 입자
CN109535057B (zh) * 2018-11-07 2020-03-10 百顺药业有限公司 一种用胆绿素Ⅸα二酯制备高含量胆红素Ⅸα的方法
CN112624953B (zh) * 2020-12-22 2023-07-21 百顺药业有限公司 胆绿素或其衍生物的制备方法
CN112479967B (zh) * 2020-12-22 2023-07-21 百顺药业有限公司 胆绿素类化合物及其制备方法和用途

Also Published As

Publication number Publication date
JP2004503556A (ja) 2004-02-05
CA2412623A1 (fr) 2001-12-20
WO2001096345A1 (fr) 2001-12-20
EP1320532A1 (fr) 2003-06-25

Similar Documents

Publication Publication Date Title
AU737650B2 (en) Substituted porphyrins
AU2001268366A1 (en) Tetrapyrroles
EP1071474B1 (fr) Porphyrines substituees
Batinić-Haberle et al. A potent superoxide dismutase mimic: manganese β-octabromo-meso-tetrakis-(N-methylpyridinium-4-yl) porphyrin
Dick et al. Molecular encapsulation: cyclodextrin-based analogs of heme-containing proteins
US6573258B2 (en) Photodynamic porphyrin antimicrobial agents
Wada et al. Copper (II)[2, 3-butanedionebis (N4-methylthiosemicarbazone)], a stable superoxide dismutase-like copper complex with high membrane penetrability
Balch et al. Isolation and characterization of an iron biliverdin-type complex that is formed along with verdohemochrome during the coupled oxidation of iron (II) octaethylporphyrin
Trova et al. Superoxide dismutase mimetics. Part 2: Synthesis and structure–activity relationship of glyoxylate-and glyoxamide-derived metalloporphyrins
EP1616869A1 (fr) Prophirines substituees et leur utilisation therapeutique
Singha et al. Effect of hydrogen bonding on innocent and non-innocent axial ligands bound to iron porphyrins
Oliveri et al. New conjugates of β-cyclodextrin with manganese (III) salophen and porphyrin complexes as antioxidant systems
US20040039211A1 (en) Tetrapyrroles
US20040058902A1 (en) Substituted porphyrins
Pearce et al. A Potential Antidote for both Azide and Cyanide Poisonings
JP3405741B2 (ja) 近位塩基を持つポルフィリン金属錯体
Shiemkeit et al. Structural and Spectroscopic Characterization of Exogenous Ligand Binding to Isolated Factor Fao and Its Configurational Isomers
Patel Pyridinones and their complexes: Preparation and structure; solvation and reactivity in micelles

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application